News — ASNRT

Latest Articles

The most recent nephrology and transplantation news curated by ASNRT.

ABO-Incompatible Kidney Transplantation as a Strategic Expansion Tool in Low- and Middle-Income Countries · A perspective on ABO incompatible transplantation. · Nondialytic Care vs Dialysis Transition on Hospitalization: Outcomes in Veterans With Advanced Chronic Kidney Disease · Adding Finerenone to SGLT2 Inhibitors and Long-Term Kidney Outcomes in Diabetic Kidney Disease · Comparative Analysis of Lupus Nephritis Guidelines: ACR 2025, EULAR 2025, and Kdigo 2024. · Pharmacological blood-pressure lowering for the prevention of cardiovascular disease and death across the full spectrum of chronic kidney disease severity: an individual-participant data meta-analysis · Clazakizumab in the Treatment of Chronic Active Antibody-Mediated Kidney Transplant Rejection: Results from the IMAGINE Phase 3 Randomized, Double-Blind, Placebo-Controlled Study · Plant-dominant low-protein diet versus standard care in adults with chronic kidney disease stages 3-5: A randomized controlled trial protocol. · Endovascular arteriovenous fistula: Outcomes and comparison with surgical arteriovenous fistula: An updated systematic review and meta-analysis. · Efficacy and Safety of Obinutuzumab in Active Systemic Lupus Erythematosus · Finerenone in Type 1 Diabetes and Chronic Kidney Disease. · SGLT2 Inhibitors vs GLP-1 Receptor Agonists for Kidney Outcomes in Individuals With Type 2 Diabetes · Vaccinations to Prevent Infections in Adults with CKD and After Kidney Transplantation: A Review · QuantiFERON-CMV Cell-Mediated Immunity to Predict Post-Prophylaxis CMV Disease in D+/R- Kidney Transplant Recipients (Phase 3 Letermovir vs Valganciclovir Trial) · FDA Accepts Oxylanthanum Carbonate NDA Resubmission for Hyperphosphatemia in CKD Dialysis · Updates on Kidney Transplantation From the World Transplant Congress 2025 · Replacing Mycophenolate Mofetil by Everolimus to Increase Vaccine Immunogenicity in Kidney Transplant Recipients: A Randomized Controlled Trial · Dual costimulation blockade with the CD154-specific fusion protein dazodalibep and belatacept for prophylaxis of kidney allograft rejection. · Phase 2 Apecotrep Delivers 40% Proteinuria Reduction in FSGS · A Conservative Dialysis Strategy and Kidney Function Recovery in Dialysis-Requiring Acute Kidney Injury: The Liberation From Acute Dialysis (LIBERATE-D) Randomized Clinical Trial. · Trends in Nephrology: From nihilism to targeted treatment of antibody-mediated rejection · Tolvaptan vs Fluid Restriction in Moderate-Profound Hyponatremia: An Open-Label Randomized Clinical Trial. · New Federal Dietary Guidelines Impact Chronic Kidney Disease Management With Tim Pflederer Md · Combined Anti-CD20/Anti-CD38 Therapy in Posttransplant Focal Segmental Glomerulosclerosis Recurrence: A Retrospective, International, Multicenter Study · SGLT2 Inhibitors and Kidney Outcomes by Glomerular Filtration Rate and Albuminuria: A Meta-Analysis · Glucagon-like receptor agonists and next-generation incretin-based medications: metabolic, cardiovascular, and renal benefits. · FDA Extends Sparsentan (Filspari) sNDA Review for Focal Segmental Glomerulosclerosis · Meta-Analysis of Randomized Controlled Trials Assessing the Efficacy and Safety of Endothelin Receptor Antagonists in CKD · FDA Grants Priority Review of Biologics License Application for Atacicept in IgA Nephropathy · Dual Targeting of B Cell Compartments Using Belatacept and Daratumumab in Highly Sensitized Kidney Transplant Candidates: A Mechanistic Proof-of-Concept Desensitization Trial · Evolving Therapeutic Approaches for Treatment of Antibody-Mediated Rejection in Renal Allograft Recipients · KDIGO Releases New Guideline For Anemia In Chronic Kidney Disease · Antiproteinuric Effect of Sparsentan in Patients with Genetic-Associated FSGS Enrolled in the DUPLEX Trial · Anti-glomerular basement membrane disease-treatment standard. · Association between Complete Proteinuria Remission and Kidney Function in the Phase 3 PROTECT Trial of Sparsentan in IgA Nephropathy. · Prospective Cohort Study of Obinutuzumab in Rituximab-Resistant Primary Membranous Nephropathy · Juvenile-onset Systemic Lupus Erythematosus: Recent Advances in Pathogenesis and Treatment. · Cardio-renal outcomes in type 2 diabetes patients with advanced chronic kidney disease on SGLT2 inhibitors or GLP-1 receptor agonists · Podocytopathies. · Sodium Bicarbonate for Severe Metabolic Acidemia and Acute Kidney Injury: The BICARICU-2 Randomized Clinical Trial

Browse by Topic

News organized by clinical subject.

Transplantation · Dialysis · Glomerulonephritis · CKD · AKI & Critical Care · Hypertension & Diabetic Kidney · Genetic & Cystic · Kidney Stones · Electrolytes & Acid-Base · Pediatric Nephrology · Cardiorenal · Society & Regulatory · General Nephrology · AJNT

Stay Connected

Subscribe to the ASNRT newsletter via the membership portal, or follow our official channels for upcoming congress announcements, journal release notifications, and clinical practice updates.